PER
Click for more information
1.22% 8.1¢ percheron therapeutics limited

Sarepta FDA Hearing, page-60

  1. cdoyle
    798 Posts.
    lightbulb Created with Sketch. 301
    clock Created with Sketch.
    16/05/23
    15:41
    Post #: 67802371
    ANP may not have to pass a P3 trial. It can be approved after P2 under orphan drug designation
    ANP Price at posting: 7.1¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 15  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GBR Great Boulder reports mineralisation over 400m of strike at Mulga Bill North
right-arrow Created with Sketch.
NEWS Unchanged wage growth in June quarter, but public sector leaps ahead
right-arrow Created with Sketch.
WAF Drilling at Kiaka Gold Project yields 7.6 g/t intercept for West African
right-arrow Created with Sketch.
AVR Anteris the latest to flee a struggling ASX for Wall Street's NASDAQ
right-arrow Created with Sketch.
STX Award of 85 MW capacity pushes Strike's Erregulla power station project closer to FID
right-arrow Created with Sketch.
NEWS Was last week's panic justified?
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
-0.001(1.22%) 		Mkt cap ! $75.72M
Open High Low Value Volume
8.3¢ 8.4¢ 8.1¢ $35.96K 434.8K

Buyers (Bids)

No. Vol. Price($)
3 144654 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 13053 2
View Market Depth
Last trade - 14.36pm 16/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.